63
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Economic analysis of Heart and Stroke Foundation of Ontario’s Hypertension Management Initiative

, , , , , , & show all
Pages 323-336 | Published online: 13 Nov 2012

References

  • Health CanadaEconomic Burden of Illness in Canada, 1998OttawaHealth Canada2002 Ref Type: Report
  • BorghiCDormiAL’ItalienGLapuertaPFranklinSSGaddiAThe relationship between systolic blood pressure and cardiovascular risk – results of the Brisighella Heart StudyJ Clin Hypertens (Greenwich)2003V475212556653
  • NealBMacMahonSChapmanNBlood Pressure Lowering Treatment Trialists’ CollaborationEffects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists’ CollaborationLancet20003561955196411130523
  • TurnbullFNealBAlgertCBlood Pressure Lowering Treatment Trialists’ CollaborationEffects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trialsArch Intern Med20051651410141915983291
  • HajjarIKotchenTATrends in the prevalence, awareness, treatment, and control of hypertension in the United States, 1988–2000JAMA200329019920612851274
  • HackamDGKhanNAHemmelgarnBRCanadian Hypertension Education ProgramThe 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 – therapyCan J Cardiol201026524925820485689
  • MargoliusDBodenheimerTControlling hypertension requires a new primary care modelAm J Manag Care201016964865020873951
  • QuinnRRHemmelgarnBRPadwalRSCanadian Hypertension Education ProgramThe 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part I – blood pressure measurement, diagnosis and assessment of riskCan J Cardiol201026524124820485688
  • TobeSWMoy Lum-KwongMVon SychowskiSKandukurKKissAFlintoftVHypertension Management Initiative (HMI): results of a prospective cohort studyJ Hum Hypertens (under submission)
  • Bank of CanadaConsumer Price Index, 2000 to Present [Webpage on internet]Accessed September 13, 2010 Available from: www.bankofcanada.ca/en/cpi.html
  • Guidelines for the Economic Evaluation of Health Technologies: Canada3rd edOttawaCanadian Agency for Drugs and Technologies in Health2006 (Report)
  • GlasgowREEmontSMillerDCAssessing delivery of the five ‘As’ for patient-centered counselingHealth Promot. Int200621324525516751630
  • D’AgostinoRBSrVasanRSPencinaMJGeneral cardiovascular risk profile for use in primary care: the Framingham Heart StudyCirculation2008117674375318212285
  • SarnakMJGreeneTWangXThe effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the modification of diet in renal disease studyAnn Intern Med200514234235115738453
  • PeetersAMamunAAWillekensFBonneuxLA cardiovascular life history. A life course analysis of the original Framingham Heart Study cohortEur Heart J200223645846611863348
  • BeckJRKassirerJPPaulkerSGA convenient approximation of life-expectancy (the “DEALE”). I. Validation of the methodAm J Med1982738838887148881
  • Statistics Canada2000Canadian Community Health Survey, 2000–2001Cycle11Statistics Canada
  • JacobsPYimRUsing Canadian Administrative Databases to Derive Economic Data for Health Technology AssessmentsOttawaCanadian Agency for Drugs and Technologies in Health2009 Available at http://www.cadth.ca/en/products/health-technology-assessment/publication/889
  • RileyGFPotoskyALLubitzJDKesslerLGMedicare payments from diagnosis to death for elderly cancer patients by stage at diagnosisMed Care19953388288417637404
  • BrownMLRileyGFPotoskyALEtzioniRDObtaining long-term disease specific costs of care: application to Medicare enrollees diagnosed with colorectal cancerMed Care1999371249125910599606
  • WijeysunderaHCMachadoMFarahatiFAssociation of temporal trends in risk factors and treatment uptake with coronary heart disease mortality, 1994–2005JAMA2010303181841184720460623
  • SchaferJLAnalysis of Incomplete Multivariate DataBoca Raton, FLChapman and Hall/CRC1997
  • StinnettAAMullahyJNet health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysisMed Decis Making199818SupplS68S809566468
  • JoffresMRHamtePRabkinSWGelskeyDHoganKFodorGPrevalence, control and awareness of high blood pressure among Canadian adults. Canadian Heart Health Surveys Research GroupCMAJ199246199722051596849
  • JoffresMRHamtePMacLeanDRL’italienGJFodorGDistribution of blood pressure and hypertension in Canada and the United StatesAm J Hypertens2001141099110511724207
  • UbelPAHirthRAChernewMEFendrickAMWhat is the price of life and why doesn’t it increase at the rate of inflation?Arch Intern Med20031631637164112885677
  • GafniABirchSIncremental cost-effectiveness ratios (ICERs): The silence of the lambdaSoc Sci Med2006622091210016325975
  • DattaSKOddoneEZOlsenMKEconomic analysis of a tailored behavioral intervention to improve blood pressure control for primary care patientsAm Heart J2010160225726320691830
  • O’BrienBConnollySJGoereeRCost-effectiveness of the implantable cardioverter-defibrillator: results from the Canadian Implantable Defibrillator Study (CIDS)Circulation20011031416142111245646
  • GoereeRBowenJMBlackhouseGEconomic evaluation of drug-eluting stents compared to bare metal stents using a large prospective study in OntarioInt J Technol Assess Health Care200925219620719331710